Skip to content
10-K

Annual Report

ImageneBio, Inc. IMA

0001193125-26-099434

← back to feed
Filed
Mar 10, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2025 · Dec 31, 2025 −$47.84M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$21.32M
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $7.5M
Cash And Equivalents FY 2025 · Dec 31, 2025 $94.53M
Cash And Equivalents restated FY 2025 · Dec 31, 2024 $12.12M
Stockholders Equity FY 2025 · Dec 31, 2025 $133.14M
Stockholders Equity restated FY 2025 · Dec 31, 2024 −$160.57M
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$126.11M
Current Liabilities FY 2025 · Dec 31, 2025 $11.23M
Current Liabilities restated FY 2025 · Dec 31, 2024 $17.21M
Total Liabilities FY 2025 · Dec 31, 2025 $19.84M
Total Liabilities restated FY 2025 · Dec 31, 2024 $17.45M
Current Assets FY 2025 · Dec 31, 2025 $140.29M
Current Assets restated FY 2025 · Dec 31, 2024 $12.47M
Total Assets FY 2025 · Dec 31, 2025 $152.98M
Total Assets restated FY 2025 · Dec 31, 2024 $15.92M
Eps Diluted FY 2025 · Dec 31, 2025 −$9.64
Eps Diluted restated FY 2025 · Dec 31, 2024 −$22.10
Eps Basic FY 2025 · Dec 31, 2025 −$9.64
Eps Basic restated FY 2025 · Dec 31, 2024 −$22.10
Sga Expense FY 2025 · Dec 31, 2025 $20.73M
Sga Expense restated FY 2025 · Dec 31, 2024 $8.39M
Rd Expense FY 2025 · Dec 31, 2025 $28.53M
Rd Expense restated FY 2025 · Dec 31, 2024 $32.11M
Net Income FY 2025 · Dec 31, 2025 −$45.35M
Net Income restated FY 2025 · Dec 31, 2024 −$36.57M
Operating Income FY 2025 · Dec 31, 2025 −$48.45M
Operating Income restated FY 2025 · Dec 31, 2024 −$37M
Revenue FY 2025 · Dec 31, 2025 $800K
Revenue FY 2025 · Dec 31, 2024 $3.5M